AstraZeneca Faces Another Setback as Galida Filing Delayed AstraZeneca Plc, the UK #39;s second-biggest drugmaker, delayed the regulatory filing of its diabetes medicine Galida by a year to 2007, a setback that comes a month after US scientists questioned  
Is this a piece of news regarding world politics, sports, business, or science and technology? 